448 related articles for article (PubMed ID: 31197599)
1. ILC3 in Axial Spondyloarthritis: the Gut Angle.
Mauro D; Macaluso F; Fasano S; Alessandro R; Ciccia F
Curr Rheumatol Rep; 2019 Jun; 21(7):37. PubMed ID: 31197599
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis.
Cuthbert RJ; Fragkakis EM; Dunsmuir R; Li Z; Coles M; Marzo-Ortega H; Giannoudis PV; Jones E; El-Sherbiny YM; McGonagle D
Arthritis Rheumatol; 2017 Sep; 69(9):1816-1822. PubMed ID: 28511289
[TBL] [Abstract][Full Text] [Related]
3. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.
Reinhardt A; Prinz I
Front Immunol; 2018; 9():885. PubMed ID: 29922283
[TBL] [Abstract][Full Text] [Related]
4. Expansion of Interleukin-22- and Granulocyte-Macrophage Colony-Stimulating Factor-Expressing, but Not Interleukin-17A-Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis.
Blijdorp ICJ; Menegatti S; van Mens LJJ; van de Sande MGH; Chen S; Hreggvidsdottir HS; Noordenbos T; Latuhihin TE; Bernink JH; Spits H; Rogge L; Baeten DLP; Yeremenko NG
Arthritis Rheumatol; 2019 Mar; 71(3):392-402. PubMed ID: 30260078
[TBL] [Abstract][Full Text] [Related]
5. Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis.
Triggianese P; Conigliaro P; Chimenti MS; Biancone L; Monteleone G; Perricone R; Monteleone I
Clin Exp Rheumatol; 2016; 34(6):1085-1093. PubMed ID: 27782868
[TBL] [Abstract][Full Text] [Related]
6. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Tsukazaki H; Kaito T
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899140
[TBL] [Abstract][Full Text] [Related]
7. Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature.
Mortier C; Quintelier K; De Craemer AS; Renson T; Deroo L; Dumas E; Verheugen E; Coudenys J; Decruy T; Lukasik Z; Van Gassen S; Saeys Y; Hoorens A; Lobatón T; Van den Bosch F; Van de Wiele T; Venken K; Elewaut D
Arthritis Rheumatol; 2023 Nov; 75(11):1969-1982. PubMed ID: 37293832
[TBL] [Abstract][Full Text] [Related]
8. Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis.
Nakamura A; Haroon N
Curr Rheumatol Rep; 2021 Apr; 23(5):31. PubMed ID: 33893896
[TBL] [Abstract][Full Text] [Related]
9. Barrier lymphocytes in spondyloarthritis.
Berlinberg A; Kuhn KA
Curr Opin Rheumatol; 2020 Jul; 32(4):343-348. PubMed ID: 32412993
[TBL] [Abstract][Full Text] [Related]
10. The gut-enthesis axis and the pathogenesis of Spondyloarthritis.
Mauro D; Nakamura A; Haroon N; Ciccia F
Semin Immunol; 2021 Dec; 58():101607. PubMed ID: 35850909
[TBL] [Abstract][Full Text] [Related]
11. Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
Rosine N; Miceli-Richard C
Front Immunol; 2020; 11():553742. PubMed ID: 33488572
[TBL] [Abstract][Full Text] [Related]
12. Targeting the interleukin-23/17 axis in axial spondyloarthritis.
Paine A; Ritchlin CT
Curr Opin Rheumatol; 2016 Jul; 28(4):359-67. PubMed ID: 27152702
[TBL] [Abstract][Full Text] [Related]
13. The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models.
Mandour M; Chen S; van de Sande MGH
Front Immunol; 2021; 12():618581. PubMed ID: 34267743
[TBL] [Abstract][Full Text] [Related]
14. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
Ciccia F; Guggino G; Rizzo A; Saieva L; Peralta S; Giardina A; Cannizzaro A; Sireci G; De Leo G; Alessandro R; Triolo G
Ann Rheum Dis; 2015 Sep; 74(9):1739-47. PubMed ID: 25902790
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis.
Yeremenko N; Paramarta JE; Baeten D
Curr Opin Rheumatol; 2014 Jul; 26(4):361-70. PubMed ID: 24827753
[TBL] [Abstract][Full Text] [Related]
16. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
Front Immunol; 2019; 10():649. PubMed ID: 30984202
[TBL] [Abstract][Full Text] [Related]
17. Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
McGonagle D; Watad A; Sharif K; Bridgewood C
Front Immunol; 2021; 12():614255. PubMed ID: 33815371
[TBL] [Abstract][Full Text] [Related]
18. IL-17 in the immunopathogenesis of spondyloarthritis.
Taams LS; Steel KJA; Srenathan U; Burns LA; Kirkham BW
Nat Rev Rheumatol; 2018 Aug; 14(8):453-466. PubMed ID: 30006601
[TBL] [Abstract][Full Text] [Related]
19. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Ceribelli A; Motta F; Vecellio M; Isailovic N; Ciccia F; Selmi C
Front Immunol; 2021; 12():622770. PubMed ID: 34149686
[TBL] [Abstract][Full Text] [Related]
20. Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.
Pedersen SJ; Maksymowych WP
Drugs; 2018 Sep; 78(14):1397-1418. PubMed ID: 30171593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
